Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39
| Errataetall: |
ErratumFor: Radiother Oncol. 2021 May;158:33-39. - PMID 33610624 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:163 |
|---|---|
| Enthalten in: |
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 163(2021) vom: 06. Okt., Seite 245 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lansu, Jules [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 26.11.2021 published: Print-Electronic ErratumFor: Radiother Oncol. 2021 May;158:33-39. - PMID 33610624 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.radonc.2021.05.018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327898518 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327898518 | ||
| 003 | DE-627 | ||
| 005 | 20231225201811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2021.05.018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM327898518 | ||
| 035 | |a (NLM)34243980 | ||
| 035 | |a (PII)S0167-8140(21)06256-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lansu, Jules |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Radiother Oncol. 2021 May;158:33-39. - PMID 33610624 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a van Houdt, Winan J |e verfasserin |4 aut | |
| 700 | 1 | |a van Langevelde, Kirsten |e verfasserin |4 aut | |
| 700 | 1 | |a van den Ende, Piet L A |e verfasserin |4 aut | |
| 700 | 1 | |a van der Graaf, Winette T A |e verfasserin |4 aut | |
| 700 | 1 | |a Schrage, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a van Boven, Hester |e verfasserin |4 aut | |
| 700 | 1 | |a Scholten, Astrid N |e verfasserin |4 aut | |
| 700 | 1 | |a Haas, Rick L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology |d 1993 |g 163(2021) vom: 06. Okt., Seite 245 |w (DE-627)NLM012598305 |x 1879-0887 |7 nnns |
| 773 | 1 | 8 | |g volume:163 |g year:2021 |g day:06 |g month:10 |g pages:245 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.radonc.2021.05.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 163 |j 2021 |b 06 |c 10 |h 245 | ||